Spencer Financial Statements From 2010 to 2025

SPPH Stock  USD 0.0001  0.00  0.00%   
Spencer Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Spencer Pharmaceutical's valuation are provided below:
Market Capitalization
1.3 M
We have found seventy-five available fundamental trend indicators for Spencer Pharmaceutical, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Spencer Pharmaceutical current fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The Spencer Pharmaceutical's current Enterprise Value is estimated to increase to about 125.9 K
Check Spencer Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spencer Pharmaceutical's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 754.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Spencer financial statements analysis is a perfect complement when working with Spencer Pharmaceutical Valuation or Volatility modules.
  
Build AI portfolio with Spencer Stock
Check out the analysis of Spencer Pharmaceutical Correlation against competitors.
For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.

Spencer Pharmaceutical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock175.9 K312 K251.2 K
Slightly volatile

Spencer Pharmaceutical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative754.6 K848.9 K925.5 K
Slightly volatile

Spencer Pharmaceutical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock145 K152.7 K197.8 K
Slightly volatile
Total Cash From Financing Activities54.7 K61.5 K67.1 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Days Sales Outstanding0.04560.04810.6006
Slightly volatile
Book Value Per Share4.664.444.5982
Slightly volatile
Capex To Depreciation0.30.290.2986
Slightly volatile
ROIC0.260.250.3275
Slightly volatile
Research And Ddevelopement To Revenue1.181.371.4817
Slightly volatile
Capex To Revenue0.00650.00690.0078
Slightly volatile
Cash Per Share0.02940.0310.1582
Slightly volatile
Current Ratio1.350.910.9349
Pretty Stable
Tangible Book Value Per Share4.664.444.5982
Slightly volatile
Receivables Turnover8.3 K7.9 K8.1 K
Slightly volatile
Shareholders Equity Per Share4.664.444.5982
Slightly volatile
Debt To Equity0.0320.0360.0392
Slightly volatile
Capex Per Share0.03620.02420.0236
Very volatile
Revenue Per Share1.943.173.2641
Very volatile
Interest Debt Per Share0.160.180.1936
Slightly volatile
Debt To Assets0.02910.03280.0357
Slightly volatile
Operating Cycle0.04560.04810.6006
Slightly volatile
Operating Profit Margin1.791.01.0297
Pretty Stable
Company Equity Multiplier1.21.261.4828
Slightly volatile
Total Debt To Capitalization0.03070.03460.0377
Slightly volatile
Return On Capital Employed0.270.260.3336
Slightly volatile
Debt Equity Ratio0.0320.0360.0392
Slightly volatile
Ebit Per Revenue1.791.01.0297
Pretty Stable
Quick Ratio1.350.910.9349
Pretty Stable
Net Income Per E B T1.11.141.0066
Slightly volatile
Cash Ratio0.06070.06390.1717
Slightly volatile
Cash Conversion Cycle0.04560.04810.6006
Slightly volatile
Days Of Sales Outstanding0.04560.04810.6006
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.720.910.9682
Pretty Stable
Fixed Asset Turnover39.2762.1264.2424
Very volatile
Debt Ratio0.02910.03280.0357
Slightly volatile
Asset Turnover5.925.635.838
Slightly volatile

Spencer Pharmaceutical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap0.590.70.7605
Slightly volatile

About Spencer Pharmaceutical Financial Statements

Investors use fundamental indicators, such as Spencer Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Spencer Pharmaceutical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research And Ddevelopement To Revenue 1.37  1.18 
Capex To Revenue 0.01  0.01 
Revenue Per Share 3.17  1.94 
Ebit Per Revenue 1.00  1.79 

Currently Active Assets on Macroaxis

When determining whether Spencer Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Spencer Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spencer Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Spencer Pharmaceutical Stock:
Check out the analysis of Spencer Pharmaceutical Correlation against competitors.
For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets
(1.42)
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spencer Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.